Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Activated innate immune system in irritable bowel syndrome?

Literature DB >> 17429012

Activated innate immune system in irritable bowel syndrome?

J Langhorst, A Wieder, A Michalsen, F Musial, G J Dobos, A Rueffer.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2007 PMID： 17429012 PMCID： PMC1954991 DOI： 10.1136/gut.2007.125005

Source DB: PubMed Journal: Gut ISSN： 0017-5749 Impact factor: 23.059

× No keyword cloud information.

9 in total

1. Mast cells in inflammatory conditions of the gastrointestinal tract.

Authors: R B HIATT; L KATZ
Journal: Am J Gastroenterol Date: 1962-05 Impact factor: 10.864

2. A peptide antibiotic from human skin.

Authors: J Harder; J Bartels; E Christophers; J M Schröder
Journal: Nature Date: 1997-06-26 Impact factor: 49.962

3. Symptoms of irritable bowel syndrome in ulcerative colitis in remission.

Authors: B Isgar; M Harman; M D Kaye; P J Whorwell
Journal: Gut Date: 1983-03 Impact factor: 23.059

4. NOD2/CARD15 mediates induction of the antimicrobial peptide human beta-defensin-2.

Authors: Eske Voss; Jan Wehkamp; Kai Wehkamp; Eduard F Stange; Jens M Schröder; Jürgen Harder
Journal: J Biol Chem Date: 2005-11-30 Impact factor: 5.157

5. Increased mast cells in the irritable bowel syndrome.

Authors: M O'Sullivan; N Clayton; N P Breslin; I Harman; C Bountra; A McLaren; C A O'Morain
Journal: Neurogastroenterol Motil Date: 2000-10 Impact factor: 3.598

6. Human beta-defensin 2 but not beta-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease.

Authors: Jan Wehkamp; Klaus Fellermann; Klaus R Herrlinger; Steffi Baxmann; Klaus Schmidt; Bettina Schwind; Michael Duchrow; Charlotte Wohlschläger; Alfred C Feller; Eduard F Stange
Journal: Eur J Gastroenterol Hepatol Date: 2002-07 Impact factor: 2.566

7. NF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium.

Authors: Jan Wehkamp; Jürgen Harder; Kai Wehkamp; Birte Wehkamp-von Meissner; Miriam Schlee; Corinne Enders; Ulrich Sonnenborn; Sabine Nuding; Stig Bengmark; Klaus Fellermann; Jens Michael Schröder; Eduard F Stange
Journal: Infect Immun Date: 2004-10 Impact factor: 3.441

8. Studies on the mechanism of bowel disturbance in ulcerative colitis.

Authors: S S Rao; N W Read; C Brown; C Bruce; C D Holdsworth
Journal: Gastroenterology Date: 1987-11 Impact factor: 22.682

9. Inducible and constitutive beta-defensins are differentially expressed in Crohn's disease and ulcerative colitis.

Authors: Jan Wehkamp; Juergen Harder; Michael Weichenthal; Oliver Mueller; Klaus R Herrlinger; Klaus Fellermann; Jens M Schroeder; Eduard F Stange
Journal: Inflamm Bowel Dis Date: 2003-07 Impact factor: 5.325

9 in total

7 in total

1. A question of survival? Interaction between probiotics and the gastrointestinal tract.

Authors: Herbert Lochs
Journal: Wien Klin Wochenschr Date: 2007 Impact factor: 1.704

2. Immune activation and gut microbes in irritable bowel syndrome.

Authors: Khaldun Al-Khatib; Henry C Lin
Journal: Gut Liver Date: 2009-03-31 Impact factor: 4.519

Review 3. Corticotropin releasing factor signaling in colon and ileum: regulation by stress and pathophysiological implications.

Authors: M Larauche; C Kiank; Y Tache
Journal: J Physiol Pharmacol Date: 2009-12 Impact factor: 3.011